Galapagos NV
GLPG
#4997
Rank
โ‚น176.01 B
Marketcap
โ‚น2,621
Share price
0.00%
Change (1 day)
8.38%
Change (1 year)

P/E ratio for Galapagos NV (GLPG)

P/E ratio as of June 2026 (TTM): -68.1

According to Galapagos NV's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -68.0718. At the end of 2025 the company had a P/E ratio of 5.70.

P/E ratio history for Galapagos NV from 2015 to 2026

PE ratio at the end of each year

Year P/E ratio Change
20255.70-75.67%
202423.4104.48%
202311.5-191.92%
2022-12.5-59.81%
2021-31.079.18%
2020-17.3-124.16%
201971.6-150.69%
2018-141323.07%
2017-33.4-164.57%
201651.7-399.85%
2015-17.2-222.8%
201414.0-125.86%
2013-54.3-27%
2012-74.4

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Johnson & Johnson
JNJ
26.8-139.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
24.5-136.03%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
108-258.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
16.6-124.39%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
32.5-147.67%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
25.6-137.60%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
13.4-119.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-5.03-92.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
23.8-134.91%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.